Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | JAK2 |
Variant | F537_K539delinsL |
Impact List | indel |
Protein Effect | gain of function |
Gene Variant Descriptions | JAK2 F537_K539delinsL results in a deletion of three amino acids of the Jak2 protein from amino acids 537 to 539, combined with the insertion of a leucine (L) at the same site (UniProt.org). F537_K539delinsL confers a gain of function to the Jak2 protein as demonstrated by increased proliferation, Jak2 phosphorylation, and downstream Stat5 phosphorylation in cell culture (PMID: 17267906). |
Associated Drug Resistance | |
Category Variants Paths |
JAK2 mutant JAK2 act mut JAK2 F537_K539delinsL JAK2 mutant JAK2 exon12 JAK2 F537_K539delinsL |
Transcript | NM_004972.4 |
gDNA | chr9:g.5070022_5070027delTCACAA |
cDNA | c.1611_1616delTCACAA |
Protein | p.F537_K539delinsL |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001322194.1 | chr9:g.5070022_5070027delTCACAA | c.1611_1616delTCACAA | p.F537_K539delinsL | RefSeq | GRCh38/hg38 |
NM_001322194.2 | chr9:g.5070022_5070027delTCACAA | c.1611_1616delTCACAA | p.F537_K539delinsL | RefSeq | GRCh38/hg38 |
NM_001322196.2 | chr9:g.5070022_5070027delTCACAA | c.1611_1616delTCACAA | p.F537_K539delinsL | RefSeq | GRCh38/hg38 |
NM_001322195.2 | chr9:g.5070022_5070027delTCACAA | c.1611_1616delTCACAA | p.F537_K539delinsL | RefSeq | GRCh38/hg38 |
NM_004972 | chr9:g.5070022_5070027delTCACAA | c.1611_1616delTCACAA | p.F537_K539delinsL | RefSeq | GRCh38/hg38 |
NM_001322196 | chr9:g.5070022_5070027delTCACAA | c.1611_1616delTCACAA | p.F537_K539delinsL | RefSeq | GRCh38/hg38 |
NM_004972.4 | chr9:g.5070022_5070027delTCACAA | c.1611_1616delTCACAA | p.F537_K539delinsL | RefSeq | GRCh38/hg38 |
NM_001322195 | chr9:g.5070022_5070027delTCACAA | c.1611_1616delTCACAA | p.F537_K539delinsL | RefSeq | GRCh38/hg38 |
NM_001322196.1 | chr9:g.5070022_5070027delTCACAA | c.1611_1616delTCACAA | p.F537_K539delinsL | RefSeq | GRCh38/hg38 |
NM_001322195.1 | chr9:g.5070022_5070027delTCACAA | c.1611_1616delTCACAA | p.F537_K539delinsL | RefSeq | GRCh38/hg38 |
NM_004972.3 | chr9:g.5070022_5070027delTCACAA | c.1611_1616delTCACAA | p.F537_K539delinsL | RefSeq | GRCh38/hg38 |
NM_001322194 | chr9:g.5070022_5070027delTCACAA | c.1611_1616delTCACAA | p.F537_K539delinsL | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|